About Us

Meet our Senior Level Management Team

Michael Spino, Pharm. D., B.Sc. Phm.


Dr. Michael Spino is the President of ApoPharma Inc. He received his B.Sc.Phm. degree from the University of Toronto in 1967 and his Pharm.D. degree from the University of California, San Francisco Medical Center in 1973, followed by a Post Doctoral Research Fellowship in Clinical Pharmacology in Toronto. He was appointed to the academic staff of the Faculty of Pharmacy, University of Toronto in 1974, where his main research interest was in the field of drug disposition, with a particular focus on Cystic Fibrosis. In 1990, Dr. Spino rose to the rank of full Professor, and continues with his appointment to the present day.

In 1991, Dr. Spino joined Apotex Inc. as VP, Scientific Affairs, where he oversaw research and development of generic drugs and initiated innovative drug development a year later. Eventually the research into new drugs resulted in the establishment of a spin-off company from Apotex, called ApoPharma Inc. As President of ApoPharma, Dr. Spino remains actively involved in all aspects of the science and the business of the company and has been able to attract key people to oversee the various departments of ApoPharma.

Fernando Tricta, M.D., M.Sc.

Vice President of Medical Affairs

Dr. Fernando Tricta, Vice President Medical Affairs, ApoPharma is a pediatric hematologist/oncologist with more than 20 years clinical experience in the management of thalassemia and other hemoglobinopathies. Prior to joining ApoPharma, Dr. Tricta established and managed the first thalassemia clinic in Brazil. Dr. Tricta has played a key role in the assessment of the safety and efficacy of Ferriprox®*(deferiprone) and in making this chelator available to patients. As Vice President, Medical Affairs of ApoPharma, Dr. Tricta has a leadership role in the clinical development of its products, and has overall responsibility for the Clinical Research, Clinical Data Management and Medical Safety Departments of the company. Other contributions include the numerous presentations, lectures and papers that Dr. Tricta has presented in the field of Hematology and Oncology.

Michael Woolcock, B.Sc.

Vice President of Sales & Marketing

Mike Woolcock, Vice President Commercial Operations, ApoPharma is an experienced leader with more than 25 years of experience in the pharmaceutical industry. In addition to his commercial experience Mr Woolcock has worked in a variety of roles in R&D in pharmaceutical and biotechnology companies. His experience in various international assignments throughout his career makes him the ideal person to lead the commercial team for ApoPharma.

John Connelly

Vice President of Regulatory Affairs and Non-Clinical Research

*Ferriprox is a registered trademark of Apotex Inc.

Leaving ApoPharma.com

You are now leaving ApoPharma Inc. This link will take you to a web site where this site’s Privacy Policy does not apply. You are solely responsible for your interactions with that web site. We encourage you to read the privacy policy of every Web site you visit.


Leaving ApoPharma.com

You have expressed an interest in looking at job openings for ApoPharma Inc. You are now leaving the ApoPharma website and entering the Apotex website. Do not be concerned, ApoPharma is a part of the Apotex group of companies. All job openings for Apotex member companies, including those for ApoPharma Inc. are found on this website.